Logo image of NDLS

NOODLES & CO (NDLS) Stock Fundamental Analysis

NASDAQ:NDLS - Nasdaq - US65540B1052 - Common Stock - Currency: USD

0.8901  +0.03 (+3.26%)

Premarket: 0.9125 +0.02 (+2.52%)

Fundamental Rating

1

Overall NDLS gets a fundamental rating of 1 out of 10. We evaluated NDLS against 135 industry peers in the Hotels, Restaurants & Leisure industry. NDLS has a bad profitability rating. Also its financial health evaluation is rather negative. NDLS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NDLS had negative earnings in the past year.
NDLS had a positive operating cash flow in the past year.
In the past 5 years NDLS reported 4 times negative net income.
NDLS had a positive operating cash flow in each of the past 5 years.
NDLS Yearly Net Income VS EBIT VS OCF VS FCFNDLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -12.25%, NDLS is doing worse than 87.41% of the companies in the same industry.
Industry RankSector Rank
ROA -12.25%
ROE N/A
ROIC N/A
ROA(3y)-4.93%
ROA(5y)-4.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NDLS Yearly ROA, ROE, ROICNDLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

With a Gross Margin value of 23.59%, NDLS is not doing good in the industry: 82.22% of the companies in the same industry are doing better.
NDLS's Gross Margin has declined in the last couple of years.
NDLS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.5%
NDLS Yearly Profit, Operating, Gross MarginsNDLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

0

2. Health

2.1 Basic Checks

NDLS does not have a ROIC to compare to the WACC, probably because it is not profitable.
NDLS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NDLS has more shares outstanding
The debt/assets ratio for NDLS is higher compared to a year ago.
NDLS Yearly Shares OutstandingNDLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NDLS Yearly Total Debt VS Total AssetsNDLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

NDLS has an Altman-Z score of 0.49. This is a bad value and indicates that NDLS is not financially healthy and even has some risk of bankruptcy.
NDLS has a worse Altman-Z score (0.49) than 78.52% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.49
ROIC/WACCN/A
WACC9.22%
NDLS Yearly LT Debt VS Equity VS FCFNDLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

NDLS has a Current Ratio of 0.29. This is a bad value and indicates that NDLS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.29, NDLS is doing worse than 88.89% of the companies in the same industry.
A Quick Ratio of 0.13 indicates that NDLS may have some problems paying its short term obligations.
NDLS has a worse Quick ratio (0.13) than 97.04% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.13
NDLS Yearly Current Assets VS Current LiabilitesNDLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

NDLS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -188.89%.
NDLS shows a decrease in Revenue. In the last year, the revenue decreased by -0.63%.
NDLS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.30% yearly.
EPS 1Y (TTM)-188.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
Revenue 1Y (TTM)-0.63%
Revenue growth 3Y1.25%
Revenue growth 5Y1.3%
Sales Q2Q%1.98%

3.2 Future

Based on estimates for the next years, NDLS will show a very strong growth in Earnings Per Share. The EPS will grow by 22.99% on average per year.
The Revenue is expected to grow by 1.81% on average over the next years.
EPS Next Y17.27%
EPS Next 2Y22.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NDLS Yearly Revenue VS EstimatesNDLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
NDLS Yearly EPS VS EstimatesNDLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NDLS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NDLS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NDLS Price Earnings VS Forward Price EarningsNDLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

NDLS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NDLS is cheaper than 81.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.78
NDLS Per share dataNDLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as NDLS's earnings are expected to grow with 22.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.99%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NDLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NOODLES & CO

NASDAQ:NDLS (5/16/2025, 8:07:36 PM)

Premarket: 0.9125 +0.02 (+2.52%)

0.8901

+0.03 (+3.26%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05
Inst Owners37.91%
Inst Owner Change-0.39%
Ins Owners4.86%
Ins Owner Change1.12%
Market Cap40.86M
Analysts84.44
Price Target2.93 (229.18%)
Short Float %1.96%
Short Ratio6.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.66%
Min EPS beat(2)-96.08%
Max EPS beat(2)-19.24%
EPS beat(4)1
Avg EPS beat(4)-53.71%
Min EPS beat(4)-107.6%
Max EPS beat(4)8.08%
EPS beat(8)3
Avg EPS beat(8)-52.27%
EPS beat(12)5
Avg EPS beat(12)-34.18%
EPS beat(16)7
Avg EPS beat(16)-32.77%
Revenue beat(2)0
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-2.15%
Max Revenue beat(2)-1.59%
Revenue beat(4)0
Avg Revenue beat(4)-3.15%
Min Revenue beat(4)-4.47%
Max Revenue beat(4)-1.59%
Revenue beat(8)0
Avg Revenue beat(8)-3.5%
Revenue beat(12)0
Avg Revenue beat(12)-2.81%
Revenue beat(16)0
Avg Revenue beat(16)-2.8%
PT rev (1m)-4.17%
PT rev (3m)-4.17%
EPS NQ rev (1m)-37.5%
EPS NQ rev (3m)21.43%
EPS NY rev (1m)-15.87%
EPS NY rev (3m)-20.33%
Revenue NQ rev (1m)1.85%
Revenue NQ rev (3m)4.43%
Revenue NY rev (1m)0.77%
Revenue NY rev (3m)3.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF 8.9
P/B N/A
P/tB N/A
EV/EBITDA 7.78
EPS(TTM)-0.52
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)0.1
OCFY11.23%
SpS10.8
BVpS-0.3
TBVpS-0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.25%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.59%
FCFM N/A
ROA(3y)-4.93%
ROA(5y)-4.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.5%
F-Score3
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 5.61
Cap/Depr 80.03%
Cap/Sales 4.65%
Interest Coverage N/A
Cash Conversion 24.09%
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.13
Altman-Z 0.49
F-Score3
WACC9.22%
ROIC/WACCN/A
Cap/Depr(3y)146.29%
Cap/Depr(5y)115.44%
Cap/Sales(3y)7.61%
Cap/Sales(5y)5.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-188.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
EPS Next Y17.27%
EPS Next 2Y22.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.63%
Revenue growth 3Y1.25%
Revenue growth 5Y1.3%
Sales Q2Q%1.98%
Revenue Next Year2.95%
Revenue Next 2Y1.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1015.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year391.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.91%
OCF growth 3Y-40.65%
OCF growth 5Y-24.12%